MD Anderson Regional Care Center-Katy

Clinical research site in Houston, Texas

As of July 2026, 1 paid clinical trial is recruiting at MD Anderson Regional Care Center-Katy in Houston, Texas. Active studies at this site focus on Acute Promyelocytic Leukemia With PML-RARA alongside other indications. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at MD Anderson Regional Care Center-Katy (1)

Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia

for Acute Promyelocytic Leukemia With PML-RARA

5 locations incl. Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 10+

Code: NCT01409161·Phase 2·Recruiting·Listed Aug 2011

Apply to this trial

More research sites in Houston

MD Anderson Cancer Center (422 trials)
M D Anderson Cancer Center (272 trials)
Baylor College of Medicine (197 trials)
The University of Texas Health Science Center at Houston (185 trials)
The University of Texas MD Anderson Cancer Center (131 trials)
Houston Methodist Hospital (128 trials)
Texas Children's Hospital (113 trials)
The University of Texas M. D. Anderson Cancer Center (85 trials)
University of Texas MD Anderson Cancer Center (83 trials)
UT MD Anderson Cancer Center (62 trials)

Explore more

Paid clinical trials in Houston, TX · Texas clinical trials